Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series

References

• Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1–ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci. 2013;33:18161–18174.
   PubMed Web of Science ®Google Scholar
• Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 2011;10:759–772.
   PubMed Web of Science ®Google Scholar
• Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with carcinoma. Brain. 1968;91:481–496.
   PubMed Web of Science ®Google Scholar
• Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–785.
   PubMed Web of Science ®Google Scholar
• Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain. 2010;133:2734–2748.
   PubMed Web of Science ®Google Scholar
• Boronat A, Sabater L, Saiz A, et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76:795–800.
   PubMed Web of Science ®Google Scholar
• Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–434.
   PubMed Web of Science ®Google Scholar
• Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.
   PubMed Web of Science ®Google Scholar
• Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840–851.
   PubMed Web of Science ®Google Scholar
• Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008;65:1341–1346.
   PubMedGoogle Scholar
• Ariño H, Armangué T, Petit-Pedrol M, et al. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome. Neurology. 2016;87:759–765.
   PubMed Web of Science ®Google Scholar
• Irani SR, Buckley C, Vincent A, et al. Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology. 2008;71:1647–1648.
   PubMed Web of Science ®Google Scholar
• Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69:892–900.
   PubMed Web of Science ®Google Scholar
• Thompson J, Bi M, Murchison AG, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141:348–356.
   PubMed Web of Science ®Google Scholar
• van Sonderen A, Roelen DL, Stoop JA, et al. Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol. 2017;81:193–198.
   PubMed Web of Science ®Google Scholar
• Kim TJ, Lee ST, Moon J, et al. Anti-LGI1 encephalitis is associated with unique HLA subtypes. Ann Neurol. 2017;81:183–192.
   PubMed Web of Science ®Google Scholar
• Fukata Y, Lovero KL, Iwanaga T, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA. 2010;107:3799–3804.
   PubMed Web of Science ®Google Scholar
• Li ZM, Cui T, Shi WX, et al. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures. Medicine (Baltimore). 2016;95:e4244.
   PubMed Web of Science ®Google Scholar
• Sen A, Wang J, Laue-Gizzi H, et al. Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies. Lancet. 2014;383:2018.
   PubMed Web of Science ®Google Scholar
• Navarro V, Kas A, Apartis E, et al. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain. 2016;139:1079–1093.
   PubMed Web of Science ®Google Scholar
• Seagar M, Russier M, Caillard O, et al. LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels. Proc Natl Acad Sci USA. 2017;114:7719–7724.
   PubMed Web of Science ®Google Scholar
• Boesebeck F, Schwarz O, Dohmen B, et al. Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas. J Neurol. 2013;260:1684–1686.
   PubMed Web of Science ®Google Scholar
• Striano P. Faciobrachial dystonic attacks: seizures or movement disorder? Ann Neurol. 2011;70:179–180.
   PubMed Web of Science ®Google Scholar
• Head K, Gong S, Joseph S, et al. Defining the expression pattern of the LGI1 gene in BAC transgenic mice. Mamm Genome. 2007;18:328–337.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Zhao YY, Wang QZ, et al. Pearls & Oy-sters: Limbic encephalitis associated with positive anti-LGI1 and antithyroid antibodies. Neurology. 2016;86:e16–e18.
   PubMed Web of Science ®Google Scholar
• Kotsenas AL, Watson RE, Pittock SJ, et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis . AJNR Am J Neuroradiol. 2014;35:84–88.
   PubMed Web of Science ®Google Scholar
• López Chiriboga AS, Siegel JL, Tatum WO, et al. Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm. 2017;4:e336.
   PubMed Web of Science ®Google Scholar
• Zuliani L, Saiz A, Tavolato B, et al. Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour. J Neurol Neurosurg Psychiatry. 2007;78:204–205.
   PubMed Web of Science ®Google Scholar
• Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology. 2011;77:179–189.
   PubMed Web of Science ®Google Scholar